Hacking Cancer Together

We dream big. We imagine a world where cancer is curable.

The Latest at the Parker Institute

Intestine
Research Updates

Could probiotics reduce immunotherapy’s chances of working in cancer patients?

November 8, 2018
Tcell
Announcements, Research Updates

PICI @ SITC 2018 Annual Meeting #SITC2018

November 7, 2018
Cancer Cell In Human Body
Press Releases

The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment

October 18, 2018
More

 The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.

World-renowned experts from leading cancer centers are at the forefront of our research.

Memorial Sloan Kettering Cancer Center
Stanford Medicine
UCLA
UCSF
Penn Medicine
MD Anderson Cancer Center
Fred Hutch Logo White
About Our Model
Parker Institute Parker Institute @parkerici Interesting research from @IcahnMountSinai re #bladdercancer. Link to paper: https://t.co/vTwKXeBps4 https://t.co/Eefyxh7erp 22 hours ago
Parker Institute Parker Institute @parkerici RT @vaccinenation: Dr Theresa Lavallee @parkerici joins our expert panel on how understanding of the tumor microbiome and the #microbiome c… 22 hours ago
Parker Institute Parker Institute @parkerici A high fiber diet 🌱 has been linked to better response to checkpoint inhibitors in cancer patients. But what about… https://t.co/DMbufUdxUc 2 days ago

Research Projects

Our investigators collaborate on high-risk, high-reward research projects

Our Partners

Working together to get much needed treatments to patients faster

For Patients

Furthering research to get treatments to patients faster

Our Model

A new approach to accelerate cancer breakthroughs

© 2018 All Rights Reserved
Member Center Login

Get Email Updates